In vivo studies |
Wound-healing disturbances, tendinopathies, and non-healing bone fractures |
Activation of angiogenic pathways with local release of trophic mediators |
[72-77] |
|
Myocardial infarction in animal models |
Improvement of vascularization at the infarction border zone; Mobilization of endogenous progenitor cells from bone marrow into the systemic circulation and to the damaged myocardium; Increase in VEGF gene and protein expression with endothelial cell proliferation |
[82-88] |
|
Human severe coronary artery disease or severe angina |
Improvement of myocardial ischemia and chest pain |
[89-90] |
|
Human acute myocardial infarction |
Suppression of left ventricular remodeling and enhancement of myocardial function |
[91] |
|
Spinal cord injury in rats |
Induction of endogenous neural stem cells and functional improvement |
[96] |
|
Diabetic bladder dysfunction in rat model |
Improvement of voiding function; Enhancement of innervation and vascularization |
[97] |
In vitro studies |
Adipose- and bone marrow-derived mesenchymal stem cells |
Induction of osteogenic differentiation |
[92-94] |
|
Murine adipose derived stem cells |
Stem cell proliferation and migration in an Erk1/2-dependent fashion |
[81,95] |